Piper Sandler Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price
Health Catalyst (NASDAQ:HCAT – Free Report) had its price target cut by Piper Sandler from $12.00 to $8.00 in a research report released on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts have also recently weighed in on the company. Citigroup reduced their price objective […]
Health Catalyst (NASDAQ:HCAT – Free Report) had its price target cut by Piper Sandler from $12.00 to $8.00 in a research report released on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts have also recently weighed in on the company. Citigroup reduced their price objective […]
